-23.1%
DASH vs MRNA
+444.4%
-467.5%
-48.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -3.4% | +1.8% | -1.5% |
| 7D | -12.8% | -10.1% | -2.7% | -12.6% |
| 30D | -6.0% | +126.7% | -132.7% | -10.6% |
| 3M | +26.7% | +184.1% | -157.4% | +16.3% |
| 6M | +11.7% | +143.3% | -131.6% | +4.2% |
| YTD | -12.9% | +359.9% | -372.8% | -23.0% |
| 1Y | -23.1% | +454.2% | -477.3% | -31.1% |
| All | -23.1% | +444.4% | -467.5% | -31.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling